Loading...

VATE INNOVATE CORP Product Launches 8-K Filing

NNVT

VT

INNOVATE CORP

(VATE)

2025 8-K

Show Summary

Show Summary

Increase in Dividend Rate

Debt Restructuring

Financial Statements

Earnings Announcement

Product Approval

Record Quarter Announcement

Earnings Announcement

NYSE Compliance

Reverse Stock Split

Earnings Reports

Unregistered Sales of Equit...

Adjournment of Annual Meeting

Earnings Reports

Unregistered Sales of Equit...

Extension of Rights Offering

Unregistered Sales of Equit...

Earnings Release

Earnings Reports

Appointment of Interim CEO

Departure of Chief Operatin...

Earnings Reports

Appointments, Resignations

Annual Meeting Voting Results

Earnings Reports

Amendment to Credit Agreement

Tax Benefits Preservation Plan

Sale of Equity Stake

Agreement, Compliance, Note...

External Links:

Innovate Corp announced that the FDA has approved its MediBeacon Transdermal GFR device for assessing kidney function in patients. This approval is significant for the company's product offerings in the healthcare sector.

AI Assistant

INNOVATE CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.